• Sorry! To unlock all site features, we'll need to collect some information from you.

  • Unit 1.5: Plaque Morphology in Acute Coronary Syndromes

    Renu Virmani, MD — CVPath, International Registry of Pathology

    Duration: 1 hour

    Faculty Disclosure

    • Grant and/or Research Support: AVE; Guidant Corporation; W.L. Gore & Associates, Inc.; Amersham Health; ev3 Inc.; Top Spin Medical (Israel) Ltd.
    • Consultant: AVE, Guidant Corporation; W.L. Gore & Associates, Inc.; Terumo Medical Corporation; Top Spin Medical (Israel) Ltd

    Learning Objectives

    • Define vulnerable plaque and explain its morphology
    • Outline the dominant causes of coronary thrombosis
    • Describe vulnerable plaque’s potential contribution to sudden coronary death
    • Discuss the development of atherosclerosis and progression to thrombosis
    • Discuss the relationship of angiogenesis to inflammation and plaque progression